DD215580A5 - Hypocholesterolaemisch aktives protein - Google Patents

Hypocholesterolaemisch aktives protein Download PDF

Info

Publication number
DD215580A5
DD215580A5 DD83258777A DD25877783A DD215580A5 DD 215580 A5 DD215580 A5 DD 215580A5 DD 83258777 A DD83258777 A DD 83258777A DD 25877783 A DD25877783 A DD 25877783A DD 215580 A5 DD215580 A5 DD 215580A5
Authority
DD
German Democratic Republic
Prior art keywords
protein
active protein
culture
microorganism
hypocholesterolemic
Prior art date
Application number
DD83258777A
Other languages
German (de)
English (en)
Inventor
Yasuo Kawai
Kazunaga Yazawa
Original Assignee
Advance Kaihatsu Kenkyusho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Kaihatsu Kenkyusho filed Critical Advance Kaihatsu Kenkyusho
Publication of DD215580A5 publication Critical patent/DD215580A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DD83258777A 1982-12-28 1983-12-28 Hypocholesterolaemisch aktives protein DD215580A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57227395A JPS59122428A (ja) 1982-12-28 1982-12-28 コレステロ−ル低下活性蛋白質

Publications (1)

Publication Number Publication Date
DD215580A5 true DD215580A5 (de) 1984-11-14

Family

ID=16860146

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83258777A DD215580A5 (de) 1982-12-28 1983-12-28 Hypocholesterolaemisch aktives protein

Country Status (12)

Country Link
US (1) US4812441A (fr)
EP (1) EP0115157B1 (fr)
JP (1) JPS59122428A (fr)
AU (1) AU568521B2 (fr)
CA (1) CA1225957A (fr)
DD (1) DD215580A5 (fr)
DE (1) DE3377654D1 (fr)
ES (1) ES8506806A1 (fr)
HU (1) HU191746B (fr)
MX (1) MX7656E (fr)
PL (1) PL140807B1 (fr)
SU (1) SU1423002A3 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753268A (en) * 1982-06-03 1998-05-19 Dcv Biologics, L.P. Anti-cholesterolemic egg, vaccine and method for production, and use
US5932250A (en) * 1982-06-03 1999-08-03 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
JPS5927833A (ja) * 1982-08-06 1984-02-14 Advance Res & Dev Co Ltd コレステロール乃至トリグリセリド低下剤
JPS59122428A (ja) * 1982-12-28 1984-07-14 Advance Res & Dev Co Ltd コレステロ−ル低下活性蛋白質
JPS61151128A (ja) * 1984-12-24 1986-07-09 Advance Res & Dev Co Ltd コレステロ−ル低下活性ｒｎａ画分
JPS625991A (ja) * 1985-07-03 1987-01-12 Advance Res & Dev Co Ltd コレステロ−ル乃至トリグリセリド低下活性ｒｎａ画分
US5248688A (en) * 1986-09-10 1993-09-28 Dudrick Medical Research Fund I, Ltd. Method and substrate composition for treating atherosclerosis
US4945157A (en) * 1988-05-27 1990-07-31 University Of Florida Novel Extraction procedure for protein G
US5006472A (en) * 1988-06-03 1991-04-09 Miles Inc. Enzymatic purification process
US5449679A (en) * 1994-07-29 1995-09-12 Leonard; Robert J. Process and products for reducing biological fluid levels of a lipid soluble waste
US5674488A (en) * 1994-10-07 1997-10-07 Reich; John J. Method for prevention and treatment of hyperchlolesterolemia by in vivo hydrogenation of cholesterol
AU6838996A (en) * 1996-05-27 1998-01-05 Alexei Nikolaevich Parfenov Use of streptococcus faecium strains and composition containing the same
CN1111512C (zh) * 1999-12-03 2003-06-18 华南农业大学 味精废水絮凝下沉物的脱水与制造饲料蛋白方法
EP1176208A1 (fr) * 2000-07-28 2002-01-30 Société des Produits Nestlé S.A. Champignons filamenteux Koji, et leur utilisation pour l'obtention de produits hypocholesterolemiants

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB930107A (en) * 1960-01-11 1963-07-03 Giuseppe Carlo Sigurta Therapeutic oral preparation of micro-organisms
FR3626M (fr) * 1963-11-13 1965-10-18 Lucien Nouvel Médicament pour affections intestinales.
DE2106154C3 (de) * 1971-02-10 1974-10-31 Morishita Pharmaceutical Co. Ltd., Osaka (Japan) Verfahren zur Herstellung eines Milchsäurebakterien-Präparates
FR2405301A1 (fr) * 1977-10-04 1979-05-04 Api Labor Substrats et procede permettant l'identification rapide de bacteries du genre streptococcus
ZA794413B (en) * 1978-09-01 1980-08-27 Us Government Protection against dental caries
US4268434A (en) * 1979-01-09 1981-05-19 Higerd Thomas B Immunosuppressive extracellular product from oral bacteria
JPS5946491B2 (ja) * 1979-03-14 1984-11-13 極東脂肪酸株式会社 喘息治療剤
JPS5946492B2 (ja) * 1979-07-12 1984-11-13 極東脂肪酸株式会社 脂質酸化抑制剤
JPS5943929B2 (ja) * 1979-08-13 1984-10-25 サッポロビール株式会社 多糖体ｒｂｓ物質，その製法およびそれを有効成分とする抗腫瘍性剤
GB2077101B (en) * 1980-05-12 1984-08-08 Kyokuto Fatty Acid Corp Antiallergic composition containing streptococci
JPS58131917A (ja) * 1982-02-01 1983-08-06 Advance Res & Dev Co Ltd 抗動脈硬化剤
DE3305047A1 (de) * 1982-02-19 1983-09-22 Terumo Kabushiki Kaisha trading as Terumo Corp., Tokyo Polysaccharide, ihre herstellung und diese enthaltende therapeutische zusammensetzungen
JPS5927833A (ja) * 1982-08-06 1984-02-14 Advance Res & Dev Co Ltd コレステロール乃至トリグリセリド低下剤
JPS59122428A (ja) * 1982-12-28 1984-07-14 Advance Res & Dev Co Ltd コレステロ−ル低下活性蛋白質
JPS6028401A (ja) * 1983-07-27 1985-02-13 Advance Res & Dev Co Ltd トリグリセリド低下活性多糖類

Also Published As

Publication number Publication date
AU568521B2 (en) 1988-01-07
ES528497A0 (es) 1985-08-01
ES8506806A1 (es) 1985-08-01
EP0115157B1 (fr) 1988-08-10
US4812441A (en) 1989-03-14
PL140807B1 (en) 1987-05-30
EP0115157A3 (en) 1985-08-07
EP0115157A2 (fr) 1984-08-08
DE3377654D1 (en) 1988-09-15
JPH0142280B2 (fr) 1989-09-11
SU1423002A3 (ru) 1988-09-07
CA1225957A (fr) 1987-08-25
HU191746B (en) 1987-04-28
JPS59122428A (ja) 1984-07-14
PL245380A1 (en) 1984-10-22
MX7656E (es) 1990-06-11
AU2224283A (en) 1984-07-05

Similar Documents

Publication Publication Date Title
EP0049847B1 (fr) Inhibiteur d'alpha-amylase, son procédé de préparation, agent à base de cet inhibiteur, et cet inhibiteur pour la régulation du taux de la glycémie
EP0366060B1 (fr) Salbostatine inhibiteur de glycosidase, méthode de sa production et son utilisation
DD215580A5 (de) Hypocholesterolaemisch aktives protein
DE2331144A1 (de) Wasserloesliche extrakte von mycobacterien
DE3017372A1 (de) Physiologisch aktive polysaccharide, verfahren zu ihrer herstellung sowie ihre verwendung
DE2024586C3 (fr)
CH641354A5 (de) Material mit antitumorwirkung und verfahren zu dessen herstellung.
DE3134353A1 (de) Antibiotikum bmg162-af2, verfahren zu seiner herstellung und es enthaltende pharmazeutische zubereitung mit antitumorwirkung
DE2701890C2 (de) Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung
DD222895A5 (de) Verfahren zur herstellung eines hypotriglyceridemisch aktiven polysaccharids
DE69107815T2 (de) Verfahren zur Herstellung neuer nichtkovalenten Polysaccharid-Protein-Zusammensetzungen mit pharmakologischen Eigenschaften.
DE2723451C2 (fr)
DE69518934T2 (de) Antibiotikum WAP-8294A, Verfahren zu seiner Herstellung und antibakterielle Zusammensetzung
DE3207019A1 (de) Biologisch wirksame proteinverbindung, verfahren zu ihrer herstellung und mittel, enthaltend die verbindung
DE2829975A1 (de) Antitumor wirksame substanz, deren herstellung und verwendung
DE3686607T2 (de) Hypocholesttrinaemisch und/oder hypotriglyceridaemisch aktive rns-fraktionen.
EP0173950A2 (fr) Inhibiteur d'alpha-glucosidase, méthode pour le préparer, son application et ses compositions pharmaceutiques
US4824945A (en) Hypocholesterolemically active RNA fractions
DE2146674C3 (de) Faktor und seine Verwendung als Arzneimittel
DE3015030C2 (fr)
DE3329255C2 (de) Verfahren zur Herstellung der Substanz TF-500 mit carcinostatischen und immunostimulierenden Eigenschaften
DE1617868A1 (de) Verfahren zur Herstellung einer anticanceroes wirksamen Substanz
DE3031152C2 (fr)
DE1642665C3 (de) Einheitliche Protease, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung mit entzündungshemmender Wirkung
DE3205074A1 (de) Neue carcinostatische und immunostimulierende substanzen, verfahren zur herstellung derselben und carcinostatische mittel mit einem gehalt derselben

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee